Skip to main content
. 2017 Apr 21;2(2):47–52. doi: 10.1136/svn-2016-000046

Figure 5.

Figure 5

The expression of Runx2 (A) and Osx (B) in BMSCs treating with TNF-α or TNF-α+Ger. # p<0.05 compared with control group, *p<0.05 compared with TNF-α group. BMSCs, bone marrow-derived mesenchymal stem cells; Ger, geraniin; TNF-α, tumour necrosis factor-alpha.